HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microalbuminuria and sRAGE in high-risk hypertensive patients treated with nifedipine/telmisartan combination treatment: a substudy of TALENT.

Abstract
Some antihypertensive drugs have also renoprotective and anti-inflammatory properties that go beyond their effect on blood pressure. It has been suggested that microalbuminuria and glomerular filtration rate (GFR) are associated with circulating levels of the soluble form of the receptor, sRAGE (soluble receptor for advanced glycation ends-products). In the present analysis, we used data from the TALENT study to evaluate soluble receptor for advanced glycation end-products (sRAGE) plasma levels in patients with hypertension and high-cardiovascular risk-treated nifedipine and telmisartan in combination. Treatment with nifedipine-telmisartan significantly decreased mean systolic and diastolic ambulatory blood pressure and resulted in a significant increase in sRAGE plasma concentrations after 24 weeks of therapy. We concluded that in hypertensive patients with early-stage renal disease, sRAGE concentrations are not influenced by either microalbuminuria or GFR. Long-term treatment with a combination of nifedipine-telmisartan may have a beneficial effect increasing sRAGE plasma levels, thus exerting an atheroprotective and anti-inflammatory activity.
AuthorsColomba Falcone, Maria Paola Buzzi, Sara Bozzini, Chiara Boiocchi, Angela D'Angelo, Sandra Schirinzi, Ciro Esposito, Massimo Torreggiani, Jasmine Choi, Michael Ochan Kilama, Giuseppe Mancia
JournalMediators of inflammation (Mediators Inflamm) Vol. 2012 Pg. 874149 ( 2012) ISSN: 1466-1861 [Electronic] United States
PMID22474401 (Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
Chemical References
  • Antihypertensive Agents
  • Benzimidazoles
  • Benzoates
  • Drug Combinations
  • Glycation End Products, Advanced
  • Nifedipine
  • Telmisartan
Topics
  • Adolescent
  • Adult
  • Aged
  • Albuminuria (blood)
  • Antihypertensive Agents (therapeutic use)
  • Benzimidazoles (therapeutic use)
  • Benzoates (therapeutic use)
  • Drug Combinations
  • Female
  • Glycation End Products, Advanced (blood)
  • Humans
  • Hypertension (blood, drug therapy)
  • Male
  • Middle Aged
  • Nifedipine (therapeutic use)
  • Telmisartan
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: